Call for proposals

14th Call for proposals 2018 - Innovative Medicines Initiative 2 Joint Undertaking - H2020-JTI-IMI2 H2020-JTI-IMI2-2018-14-TWO-STAGE Closed!

The Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) has been created following the principles below:

Research related to the future of medicine should be undertaken in areas where societal, public health and biomedical industry competitiveness goals are aligned and require the pooling of resources and greater collaboration between the public and private sectors, with the involvement of Small- and Medium- sized Enterprises (SMEs).
The scope of the initiative should be expanded to all areas of life science research and innovation.
The areas should be of public health interest, as identified by the World Health Organisation (WHO) report on priority medicines for Europe and the World

This call covers the following topics:

IMI2-2018-14-01: Targeted immune intervention for the management of non-response and relapse
IMI2-2018-14-02: Non-invasive clinical molecular imaging of immune cells
IMI2-2018-14-03: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
IMI2-2018-14-04: Centre Of Excellence – Remote Decentralised Clinical Trials

The Community provisional funding available for the call for proposals is:

14 June 2018 - more than one year ago (Deadline for the presentation of proposals)
11 December 2018 - one year ago (Deadline for the presentation of proposals)

Opened to the following bodies or institutes with legal status established in the covered areas:

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

Directorate-General for Research